A detailed history of Oppenheimer Asset Management Inc. transactions in Bio Techne Corp stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 64,609 shares of TECH stock, worth $4.62 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
64,609
Previous 62,593 3.22%
Holding current value
$4.62 Million
Previous $4.83 Million 5.84%
% of portfolio
0.07%
Previous 0.07%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$65.98 - $77.09 $133,015 - $155,413
2,016 Added 3.22%
64,609 $4.55 Million
Q4 2023

Feb 13, 2024

SELL
$52.83 - $78.22 $36,452 - $53,971
-690 Reduced 1.09%
62,593 $4.83 Million
Q3 2023

Nov 07, 2023

BUY
$67.52 - $89.42 $42,267 - $55,976
626 Added 1.0%
63,283 $4.31 Million
Q2 2023

Aug 02, 2023

SELL
$73.76 - $85.98 $75,087 - $87,527
-1,018 Reduced 1.6%
62,657 $5.11 Million
Q1 2023

May 10, 2023

BUY
$71.62 - $86.62 $194,806 - $235,606
2,720 Added 4.46%
63,675 $4.72 Million
Q4 2022

Feb 06, 2023

BUY
$80.67 - $352.29 $3.64 Million - $15.9 Million
45,119 Added 284.91%
60,955 $5.05 Million
Q3 2022

Nov 14, 2022

SELL
$282.54 - $391.85 $92,108 - $127,743
-326 Reduced 2.02%
15,836 $4.5 Million
Q2 2022

Aug 08, 2022

SELL
$322.67 - $449.65 $176,823 - $246,408
-548 Reduced 3.28%
16,162 $5.6 Million
Q1 2022

May 12, 2022

SELL
$353.85 - $487.79 $257,248 - $354,623
-727 Reduced 4.17%
16,710 $7.24 Million
Q4 2021

Feb 02, 2022

BUY
$456.15 - $525.06 $12,316 - $14,176
27 Added 0.16%
17,437 $9.02 Million
Q3 2021

Nov 12, 2021

SELL
$444.87 - $538.88 $379,029 - $459,125
-852 Reduced 4.67%
17,410 $8.44 Million
Q2 2021

Aug 03, 2021

SELL
$387.35 - $450.26 $144,481 - $167,946
-373 Reduced 2.0%
18,262 $8.22 Million
Q1 2021

May 17, 2021

SELL
$314.62 - $411.0 $767,358 - $1 Million
-2,439 Reduced 11.57%
18,635 $7.12 Million
Q4 2020

Feb 11, 2021

BUY
$246.9 - $321.87 $5,184 - $6,759
21 Added 0.1%
21,074 $6.69 Million
Q3 2020

Nov 13, 2020

BUY
$232.22 - $282.96 $45,747 - $55,743
197 Added 0.94%
21,053 $5.22 Million
Q2 2020

Aug 11, 2020

BUY
$185.43 - $279.56 $46,357 - $69,890
250 Added 1.21%
20,856 $5.51 Million
Q1 2020

May 08, 2020

BUY
$161.17 - $221.51 $279,791 - $384,541
1,736 Added 9.2%
20,606 $3.91 Million
Q4 2019

Feb 07, 2020

SELL
$189.68 - $222.09 $10,053 - $11,770
-53 Reduced 0.28%
18,870 $4.14 Million
Q3 2019

Oct 31, 2019

SELL
$183.56 - $216.72 $58,372 - $68,916
-318 Reduced 1.65%
18,923 $3.7 Million
Q2 2019

Aug 09, 2019

BUY
$188.72 - $215.43 $49,067 - $56,011
260 Added 1.37%
19,241 $4.01 Million
Q1 2019

Apr 24, 2019

BUY
$136.09 - $200.44 $96,215 - $141,711
707 Added 3.87%
18,981 $3.77 Million
Q4 2018

Jan 30, 2019

BUY
$132.75 - $203.8 $78,588 - $120,649
592 Added 3.35%
18,274 $2.64 Million
Q3 2018

Oct 26, 2018

BUY
$147.44 - $204.11 $303,873 - $420,670
2,061 Added 13.19%
17,682 $3.61 Million
Q2 2018

Aug 10, 2018

BUY
$144.9 - $165.58 $256,762 - $293,407
1,772 Added 12.8%
15,621 $2.31 Million
Q1 2018

May 09, 2018

BUY
$131.46 - $151.04 $219,406 - $252,085
1,669 Added 13.7%
13,849 $2.09 Million
Q3 2017

Nov 14, 2017

BUY
$113.59 - $123.78 $1.38 Million - $1.51 Million
12,180
12,180 $1.47 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.8B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Oppenheimer Asset Management Inc. Portfolio

Follow Oppenheimer Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.